Hokuriku Pharmaceutical announced that recently, the company received the “Drug Registration Certificate” for sildenafil citrate tablets approved and issued by the State Drug Administration. Sildenafil is a type 5 phosphodiesterase selective inhibitor used to treat erectile dysfunction. It has the advantages of rapid effect and accurate curative effect. Sildenafil citrate tablets are an iterative dosage form of sildenafil developed by Pfizer of the United States and approved for import in China in 2019. Sildenafil citrate tablets can be dissolved without the patient drinking water or placed in the mouth for a few seconds. They can meet the needs of such patients for oral medications that are easy to take, quick to take, and have good privacy, and provide patients with more flexible and diverse medication choices.

Hokuriku Pharmaceutical announced that recently, the company received the “Drug Registration Certificate” for sildenafil citrate tablets approved and issued by the State Drug Administration. Sildenafil is a type 5 phosphodiesterase selective inhibitor used to treat erectile dysfunction. It has the advantages of rapid effect and accurate curative effect. Sildenafil citrate tablets are an iterative dosage form of sildenafil developed by Pfizer of the United States and approved for import in China in 2019. Sildenafil citrate tablets can be dissolved without the patient drinking water or placed in the mouth for a few seconds. They can meet the needs of such patients for oral medications that are easy to take, quick to take, and have good privacy, and provide patients with more flexible and diverse medication choices.